Phase I/II study of adjuvant immunotherapy with sentinel lymph node T lymphocytes in patients with colorectal cancer

Although the development of multi-disciplinary management has improved the survival of colorectal cancer (CRC), the prognosis of metastatic CRC patients remains poor. Accumulating evidence has demonstrated that immunotherapy with cancer vaccines and adoptive T cell transfusions may improve outcomes...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Immunol Immunother
Glavni autori: Zhen, Yun-Huan, Liu, Xiao-Hui, Yang, Yuan, Li, Bo, Tang, Jing-Ling, Zeng, Qiang-Xing, Hu, Jie, Zeng, Xing-Nan, Zhang, Lu, Wang, Ze-Jun, Li, Xiao-Yun, Ge, Hui-Xin, Winqvist, Ola, Hu, Ping-Sheng, Xiu, Jin
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4540776/
https://ncbi.nlm.nih.gov/pubmed/25990075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-015-1715-3
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items